BioCentury
ARTICLE | Clinical News

RP101: Phase II start

August 21, 2006 7:00 AM UTC

By early next year, AVTO will begin a Phase II trial comparing 750 mg daily of RP101 plus gemcitabine to gemcitabine plus placebo. ...